Entities tied to Alvotech CEO and Board acquire $59.5M in shares
ALVO is trading near its 52-week low of $4.32 (6.9% above the low) on light trading volume (0.2× avg).
Summary
Entities closely associated with Alvotech's CEO and Board members collectively acquired approximately $59.5 million worth of shares in December 2025, signaling strong insider confidence.
Key Events · Ownership and Investor Activity · ALVO
-
Significant Insider Purchases
Two entities, Alvogen Lux Holdings S.a. r.l. and ATP Holdings ehf., collectively acquired approximately $59.5 million in Alvotech shares.
-
Closely Associated Persons
These acquiring entities are closely associated with Alvotech's CEO and Chairman, Róbert Wessman, and other board members Tomas Ekman and Arni Hardarson.
-
Transaction Details
The shares were acquired at SEK 44.06 per share across multiple transactions on December 17 and December 19, 2025.
Analysis · ALVO · Life Sciences
This 6-K filing reports substantial insider buying by entities linked to Alvotech's top leadership. The collective acquisition of approximately $59.5 million in shares represents a significant vote of confidence from those with the deepest understanding of the company's operations and future prospects. Such a large-scale purchase, especially by entities associated with the CEO and Chairman, often signals that insiders believe the stock is undervalued or that positive developments are anticipated. Investors should view this as a strong positive indicator, suggesting potential upside.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 41.1% of the 372 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALVO was trading at $4.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $4.32 to $13.70. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.